1. Home
  2. XBP vs CVM Comparison

XBP vs CVM Comparison

Compare XBP & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBP
  • CVM
  • Stock Information
  • Founded
  • XBP N/A
  • CVM 1983
  • Country
  • XBP United Kingdom
  • CVM United States
  • Employees
  • XBP N/A
  • CVM N/A
  • Industry
  • XBP Business Services
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XBP Consumer Discretionary
  • CVM Health Care
  • Exchange
  • XBP Nasdaq
  • CVM Nasdaq
  • Market Cap
  • XBP 32.0M
  • CVM 40.1M
  • IPO Year
  • XBP N/A
  • CVM 1987
  • Fundamental
  • Price
  • XBP $1.09
  • CVM $0.43
  • Analyst Decision
  • XBP
  • CVM
  • Analyst Count
  • XBP 0
  • CVM 0
  • Target Price
  • XBP N/A
  • CVM N/A
  • AVG Volume (30 Days)
  • XBP 197.8K
  • CVM 1.9M
  • Earning Date
  • XBP 11-12-2024
  • CVM 02-12-2025
  • Dividend Yield
  • XBP N/A
  • CVM N/A
  • EPS Growth
  • XBP N/A
  • CVM N/A
  • EPS
  • XBP N/A
  • CVM N/A
  • Revenue
  • XBP $157,146,000.00
  • CVM N/A
  • Revenue This Year
  • XBP N/A
  • CVM N/A
  • Revenue Next Year
  • XBP N/A
  • CVM $3,412.81
  • P/E Ratio
  • XBP N/A
  • CVM N/A
  • Revenue Growth
  • XBP N/A
  • CVM N/A
  • 52 Week Low
  • XBP $0.79
  • CVM $0.37
  • 52 Week High
  • XBP $5.55
  • CVM $3.08
  • Technical
  • Relative Strength Index (RSI)
  • XBP 48.86
  • CVM 36.29
  • Support Level
  • XBP $0.98
  • CVM $0.37
  • Resistance Level
  • XBP $1.22
  • CVM $0.44
  • Average True Range (ATR)
  • XBP 0.21
  • CVM 0.10
  • MACD
  • XBP 0.00
  • CVM -0.03
  • Stochastic Oscillator
  • XBP 27.52
  • CVM 8.47

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: